Effectiveness of Intrapartum Azithromycin to Prevent Infections in Planned Vaginal Births in Low-Income and Middle-Income Countries
May 12, 2025
In 2023, the Azithromycin Prevention in Labor Use (A-PLUS) trial showed that intrapartum azithromycin reduces maternal sepsis or death in women with planned vaginal delivery in low-resource settings, but whether it reduces maternal infection is unknown. Melissa Bauserman, MD, MPH, DTM&H, and Jackie Patterson, MD, MPH, performed a post hoc...